Browse

Last summer, zero biotechs made it onto the public markets as the industry weathered a seven-month dry spell for initial share sales. This time around, it's a summer IPO party as six

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

The number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026